Latest KFF Health News Stories
With Drug Costs In Crosshairs, Health Firms Gave Generously To Trump’s Inauguration
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump’s inauguration, which earned them entry into private events with the president and vice president.
Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
California Presses Forward In Fight To Regulate Pharma
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
¿Siente dolor? Muchos médicos dicen que los analgésicos no son la solución
Muchos médicos ya no recetan generosamente analgésicos opioides como la oxicodona o el fentanilo para el dolor de espalda o las migrañas. En cambio, recurren cada vez más a opciones no farmacológicas como la acupuntura y la fisioterapia.
In Pain? Many Doctors Say Opioids Are Not The Answer
The opioid addiction crisis has led to a crackdown on prescriptions for chronic pain patients, who are increasingly given less addictive painkillers along with referrals for acupuncture, physical therapy, massage and even yoga.
GAO To Launch Investigation Of FDA’s Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
HMO Doctors Take Pains To Slash Opioid Prescriptions
A Kaiser Permanente pain management program in Southern California aims to help patients taper off addictive painkillers. Some doctors and patients see it as a godsend; others complain that patients have been cut off medications they need.
To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies
Blue Shield of California is hoping to steer consumers to “preferred” pharmacies where drugs are cheaper and copays lower.
Trump, Dems Look For Common Ground On Drug Prices
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
Making Multiple Drugs In One Factory Risks Scary Side Effect Of Shortages
Hundreds of drug brands are being made in giant contract facilities. When a plant shuts down, a widespread drain on supply can result.
President Trump And I Take The Same Drugs — Except One
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
Los geriatras pueden ayudar a los pacientes a superar enfermedades múltiples
Nadie entiende mejor que estos especialistas en envejecimiento cómo múltiples problemas médicos interactúan en las personas mayores, y cómo pueden afectar su calidad de vida. Sin embargo, su papel en el sistema de atención de salud sigue siendo poco comprendido y sus conocimientos, subutilizados.
Geriatricians Can Help Aging Patients Navigate Multiple Ailments
Aging adults with complex needs can get special assistance from doctors trained as geriatricians.
Docs In Northwest Tweak Aid-In-Dying Drugs To Prevent Prolonged Deaths
Some terminal patients, typically high-dose opioid users, who choose to end their lives have taken many hours, even days, to die.
Health Law’s 10 Essential Benefits: A Look At What’s At Risk In GOP Overhaul
The woman set to run the federal Centers for Medicare & Medicaid Services told senators last week that maternity coverage should be optional in individual and small group plans. But other services could also be left on the cutting room floor.
Former FDA Chief Cites 5 Things To Watch On Drug Approvals And Keeping Drugs Safe
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
Drugmaker Marathon ‘Pausing’ Delivery Of $89,000-A-Year Muscular Dystrophy Drug
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
